Rising Cellular Immune Response after Injection of pVax/iutA: A Genetic DNA Cassette as Candidate Vaccine against Urinary Tract Infection
- PMID: 27516995
- PMCID: PMC4980343
Rising Cellular Immune Response after Injection of pVax/iutA: A Genetic DNA Cassette as Candidate Vaccine against Urinary Tract Infection
Abstract
Background: Uropathogenic Escherichia coli (UPEC) are major bacterial agent of Urinary Tract Infection (UTI). This infection is more prevalent among women because approximately half of all women will experience a UTI in their life-time and near a quarter of them will have a recurrent infection within 6-12 months. IutA protein has a major role during UPEC pathogenesis and consequently infection. Therefore, the aim of current study was assessment of IutA protein roles as a potential candidate antigen based for vaccine designing.
Methods: This survey was conducted during 2014-2015 at the University of Tehran, Iran. Chromosomal DNA extracted from E. coli 35218 and iutA gene amplified by PCR. The amplicon cloned to pVax.1 eukaryotic expression vector and recombinant vector confirmed by sequencing. The iutA gene expression in genetic cassette of pVax/iutA was evaluated in COS7 cell line by RT-PCR. Then, injected to mouse model, which divided to three groups: injected with pVax vector, PBS and pVax/iutA cassette respectively in two stages (d 1 and 14). One week after the second injection, bleeding from immunized mouse was performed and IFN-gamma was measured.
Results: The mice immunized with pVax/iutA showed increased interferon-γ responses significantly higher than two non-immunized groups (P<0.05).
Conclusion: Cellular immune response has a main protective role against UTI. Raising this kind of immune response is important to preventing of recurrent infection. Moreover, the current DNA cassette will be valuable for more trying to prepare a new vaccine against UTI.
Keywords: Genetic vaccination; IutA; Uropathogenic Escherichia coli.
Figures



Similar articles
-
Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine.Clin Exp Vaccine Res. 2014 Jul;3(2):185-93. doi: 10.7774/cevr.2014.3.2.185. Epub 2014 Jun 20. Clin Exp Vaccine Res. 2014. PMID: 25003092 Free PMC article.
-
Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.Exp Parasitol. 2014 Apr;139:42-8. doi: 10.1016/j.exppara.2014.02.016. Epub 2014 Mar 3. Exp Parasitol. 2014. PMID: 24602875
-
Evaluation of mammalian codon usage of fimH in DNA vaccine design.Acta Microbiol Immunol Hung. 2011 Dec;58(4):259-71. doi: 10.1556/AMicr.58.2011.4.2. Acta Microbiol Immunol Hung. 2011. PMID: 22207284
-
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.Dan Med Bull. 2011 Apr;58(4):B4187. Dan Med Bull. 2011. PMID: 21466767 Review.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
Cited by
-
Immunoinformatics-driven design and computational analysis of a multiepitope vaccine targeting uropathogenic Escherichia coli.In Silico Pharmacol. 2024 Dec 21;13(1):2. doi: 10.1007/s40203-024-00288-z. eCollection 2025. In Silico Pharmacol. 2024. PMID: 39717385
-
In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli.Sci Rep. 2020 Oct 1;10(1):16258. doi: 10.1038/s41598-020-73179-w. Sci Rep. 2020. PMID: 33004862 Free PMC article.
-
Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges.Gut Microbes. 2024 Jan-Dec;16(1):2359691. doi: 10.1080/19490976.2024.2359691. Epub 2024 Jun 2. Gut Microbes. 2024. PMID: 38825856 Free PMC article. Review.
References
-
- Hooton TM. Recurrent urinary tract infection in women (2001). Int J Antimicrob Agents, 17 (4): 259– 68. - PubMed
-
- Dodson KW, Pinkner JS, Rose T, Magnusson G, Hultgren SJ, Waksman G. (2001). Structural Basis of the Interaction of the Pyelonephritic E. coli Adhesin to Its Human Kidney Receptor. Cell, 105 ( 6): 733–43. - PubMed
-
- Svanborg C, Godaly G. (1997). Bacterial virulence in urinary tract infection. Infect Dis Clin North Am, 11 ( 3): 513–29. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources